198 related articles for article (PubMed ID: 23295150)
41. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
42. KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA.
Zeng H; Zhao D; Mukhopadhyay D
J Biol Chem; 2002 Nov; 277(48):46791-8. PubMed ID: 12244099
[TBL] [Abstract][Full Text] [Related]
43. Promoted Chondrogenesis of Cocultured Chondrocytes and Mesenchymal Stem Cells under Hypoxia Using In-situ Forming Degradable Hydrogel Scaffolds.
Huang X; Hou Y; Zhong L; Huang D; Qian H; Karperien M; Chen W
Biomacromolecules; 2018 Jan; 19(1):94-102. PubMed ID: 29211452
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia-induced upregulation of endothelial small G protein RhoA and Rho-kinase/ROCK2 inhibits eNOS expression.
Jin HG; Yamashita H; Nagano Y; Fukuba H; Hiji M; Ohtsuki T; Takahashi T; Kohriyama T; Kaibuchi K; Matsumoto M
Neurosci Lett; 2006 Nov; 408(1):62-7. PubMed ID: 16996686
[TBL] [Abstract][Full Text] [Related]
45. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.
van Nieuw Amerongen GP; Koolwijk P; Versteilen A; van Hinsbergh VW
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):211-7. PubMed ID: 12588761
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia-induced ARHGAP26 deficiency inhibits the proliferation and migration of human ductus arteriosus smooth muscle cell through activating RhoA-ROCK-PTEN pathway.
Li M; Ye L; Ye X; Wang S; Zhang H; Liu J; Hong H
J Cell Biochem; 2019 Jun; 120(6):10106-10117. PubMed ID: 30592323
[TBL] [Abstract][Full Text] [Related]
47. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy.
Risbud MV; Albert TJ; Guttapalli A; Vresilovic EJ; Hillibrand AS; Vaccaro AR; Shapiro IM
Spine (Phila Pa 1976); 2004 Dec; 29(23):2627-32. PubMed ID: 15564911
[TBL] [Abstract][Full Text] [Related]
48. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
[TBL] [Abstract][Full Text] [Related]
49. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.
Liu W; Li L; Rong Y; Qian D; Chen J; Zhou Z; Luo Y; Jiang D; Cheng L; Zhao S; Kong F; Wang J; Zhou Z; Xu T; Gong F; Huang Y; Gu C; Zhao X; Bai J; Wang F; Zhao W; Zhang L; Li X; Yin G; Fan J; Cai W
Acta Biomater; 2020 Feb; 103():196-212. PubMed ID: 31857259
[TBL] [Abstract][Full Text] [Related]
50. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.
Shi H; Patschan D; Dietz GP; Bähr M; Plotkin M; Goligorsky MS
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F229-35. PubMed ID: 18003856
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth.
Zhu W; Huang L; Li Y; Qian H; Shan X; Yan Y; Mao F; Wu X; Xu WR
Cell Cycle; 2011 Sep; 10(18):3198-207. PubMed ID: 21900753
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders.
Dell'Aversana C; Cuomo F; Botti C; Maione C; Carissimo A; Casamassimi A; Altucci L; Cobellis G
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884856
[TBL] [Abstract][Full Text] [Related]
53. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
54. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
Tang YL; Zhu W; Cheng M; Chen L; Zhang J; Sun T; Kishore R; Phillips MI; Losordo DW; Qin G
Circ Res; 2009 May; 104(10):1209-16. PubMed ID: 19407239
[TBL] [Abstract][Full Text] [Related]
55. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms.
Akram KM; Samad S; Spiteri MA; Forsyth NR
Respir Res; 2013 Jan; 14(1):9. PubMed ID: 23350749
[TBL] [Abstract][Full Text] [Related]
57. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A
J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071
[TBL] [Abstract][Full Text] [Related]
58. Migration of human mesenchymal stem cells under low shear stress mediated by mitogen-activated protein kinase signaling.
Yuan L; Sakamoto N; Song G; Sato M
Stem Cells Dev; 2012 Sep; 21(13):2520-30. PubMed ID: 22375921
[TBL] [Abstract][Full Text] [Related]
59. Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells.
Schraufstatter IU; DiScipio RG; Khaldoyanidi SK
J Stem Cells; 2009; 4(4):203-15. PubMed ID: 20720594
[TBL] [Abstract][Full Text] [Related]
60. The Role of Dissolved Oxygen Levels on Human Mesenchymal Stem Cell Culture Success, Regulatory Compliance, and Therapeutic Potential.
Bahsoun S; Coopman K; Forsyth NR; Akam EC
Stem Cells Dev; 2018 Oct; 27(19):1303-1321. PubMed ID: 30003826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
